Jeff Yass’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$32M Buy
875,800
+361,900
+70% +$13.1M ﹤0.01% 1889
2026
Q2
$18.2M Buy
513,900
+143,800
+39% +$4.25M ﹤0.01% 2576
2026
Q1
$10.3M Sell
370,100
-993,700
-73% -$25.5M ﹤0.01% 3079
2025
Q4
$29.6M Buy
1,363,800
+350,300
+35% +$6.91M ﹤0.01% 1836
2025
Q3
$15.3M Buy
1,013,500
+725,700
+252% +$8.98M ﹤0.01% 2492
2025
Q2
$3.24M Buy
287,800
+63,500
+28% +$688K ﹤0.01% 4814
2025
Q1
$2.26M Sell
224,300
-49,700
-18% -$537K ﹤0.01% 5246
2024
Q4
$3.24M Sell
274,000
-93,200
-25% -$1.1M ﹤0.01% 4331
2024
Q3
$4.24M Sell
367,200
-153,200
-29% -$1.74M ﹤0.01% 3878
2024
Q2
$5.5M Buy
520,400
+115,000
+28% +$1.26M ﹤0.01% 3297
2024
Q1
$4.27M Sell
405,400
-891,100
-69% -$9.6M ﹤0.01% 3896
2023
Q4
$14.6M Buy
1,296,500
+878,100
+210% +$8.56M ﹤0.01% 2154
2023
Q3
$4.89M Buy
418,400
+137,700
+49% +$1.56M ﹤0.01% 3569
2023
Q2
$2.83M Buy
280,700
+127,000
+83% +$1.14M ﹤0.01% 4469
2023
Q1
$1.13M Buy
153,700
+12,400
+9% +$102K ﹤0.01% 6484
2022
Q4
$1.13M Buy
+141,300
New +$786K ﹤0.01% 5899

Other funds holding ROIV

Jeff Yass's ROIV Position: Q3 2026 in Review

Jeff Yass reduced its Roivant Sciences (ROIV) stake by 96% in Q3 2026, selling an estimated $45.2M and leaving 55,771 shares worth $2.04M. The position accounts for ﹤0.01% of the portfolio, ranked #6216.

Jeff Yass first reported a position in ROIV in Q4 2021 and has held it in 19 quarters since. The position peaked at $46M in Q2 2026. 522 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.

  • Jeff Yass held 55,771 shares of Roivant Sciences worth $2.04M as of Q3 2026.
  • Jeff Yass sold 1,245,242 Roivant Sciences shares in Q3 2026, an estimated $45.2M.
  • Roivant Sciences made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #6216 holding.
  • Jeff Yass first reported a position in Roivant Sciences in Q4 2021 and has held it in 19 quarters since.
  • Jeff Yass's Roivant Sciences position peaked at $46M in Q2 2026.
  • 522 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.